{"transactions":[{"id":746368,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-08T21:00:11.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted shares (\"Shares\") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted shares (\"Shares\") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date."}],"balance_after":881333,"source":{"system":"sec-edgar","filing":"0001104659-26-071436","document":"tm2617013-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465926071436/tm2617013-1_4seq1.xml","form_type":"4"}},{"id":748139,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":40969,"kind":"person","name":"Boctor Fady","position":1,"cik":"0001833394","reported_name":"Boctor Fady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-05T21:25:09.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted shares (\"Shares\") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted shares (\"Shares\") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date."}],"balance_after":894986,"source":{"system":"sec-edgar","filing":"0001104659-26-071048","document":"tm2617013-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465926071048/tm2617013-3_4seq1.xml","form_type":"4"}},{"id":748138,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T21:12:53.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":1875000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted shares (\"Shares\") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted shares (\"Shares\") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date."}],"balance_after":3762334,"source":{"system":"sec-edgar","filing":"0001104659-26-071039","document":"tm2617013-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465926071039/tm2617013-2_4seq1.xml","form_type":"4"}},{"id":748137,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T21:12:14.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":4375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted shares (\"Shares\") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted shares (\"Shares\") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date."}],"balance_after":8790450,"source":{"system":"sec-edgar","filing":"0001104659-26-071038","document":"tm2617013-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465926071038/tm2617013-4_4seq1.xml","form_type":"4"}},{"id":946962,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":40969,"kind":"person","name":"Boctor Fady","position":1,"cik":"0001833394","reported_name":"Boctor Fady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-06T22:30:07.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amounts adjusted for the Issuer's 1-for-25 reverse stock split of the Issuer's Common Stock, effective as of 4:05 p.m. (New York time) on April 30, 2025."}],"balance_after":519986,"source":{"system":"sec-edgar","filing":"0001104659-26-001417","document":"tm261718-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465926001417/tm261718-2_4seq1.xml","form_type":"4"}},{"id":955275,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T22:00:51.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":4375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amounts adjusted for the Issuer's 1-for-25 reverse stock split of the Issuer's Common Stock, effective as of 4:05 p.m. (New York time) on April 30, 2025."}],"balance_after":4415450,"source":{"system":"sec-edgar","filing":"0001104659-26-000238","document":"tm261718-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465926000238/tm261718-4_4seq1.xml","form_type":"4"}},{"id":955274,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T22:00:36.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amounts adjusted for the Issuer's 1-for-25 reverse stock split of the Issuer's Common Stock, effective as of 4:05 p.m. (New York time) on April 30, 2025."}],"balance_after":506333,"source":{"system":"sec-edgar","filing":"0001104659-26-000237","document":"tm261718-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465926000237/tm261718-3_4seq1.xml","form_type":"4"}},{"id":955273,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T22:00:19.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":1875000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amounts adjusted for the Issuer's 1-for-25 reverse stock split of the Issuer's Common Stock, effective as of 4:05 p.m. (New York time) on April 30, 2025."}],"balance_after":1887334,"source":{"system":"sec-edgar","filing":"0001104659-26-000233","document":"tm261718-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465926000233/tm261718-1_4seq1.xml","form_type":"4"}},{"id":1253123,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-21T22:36:07.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date."}],"balance_after":158314,"source":{"system":"sec-edgar","filing":"0001104659-25-016203","document":"tm257316-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465925016203/tm257316-5_4seq1.xml","form_type":"4"}},{"id":1253122,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":82913,"kind":"person","name":"Arnold Mitchell","position":1,"cik":"0001841497","reported_name":"Arnold Mitchell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-21T22:34:57.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001104659-25-016202","document":"tm257316-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465925016202/tm257316-4_4seq1.xml","form_type":"4"}},{"id":1253121,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-21T22:33:12.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date."}],"balance_after":1011237,"source":{"system":"sec-edgar","filing":"0001104659-25-016201","document":"tm257316-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465925016201/tm257316-3_4seq1.xml","form_type":"4"}},{"id":1253120,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":40969,"kind":"person","name":"Boctor Fady","position":1,"cik":"0001833394","reported_name":"Boctor Fady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-21T22:31:45.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date."}],"balance_after":499645,"source":{"system":"sec-edgar","filing":"0001104659-25-016200","document":"tm257316-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465925016200/tm257316-2_4seq1.xml","form_type":"4"}},{"id":1253119,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-21T22:30:27.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date."}],"balance_after":308346,"source":{"system":"sec-edgar","filing":"0001104659-25-016197","document":"tm257316-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465925016197/tm257316-1_4seq1.xml","form_type":"4"}},{"id":1700182,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-26T22:08:07.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on April 10, 2024, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. through the vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-23-129255","document":"tm2333705-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923129255/tm2333705-3_4seq1.xml","form_type":"4"}},{"id":1700181,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":40969,"kind":"person","name":"Boctor Fady","position":1,"cik":"0001833394","reported_name":"Boctor Fady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-26T22:07:49.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":54533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vested 50% upon the date of grant, and the remainder vests upon the achievement of certain performance goals, provided that the Reporting Person has continued to provide services to the Company through the vesting date."}],"balance_after":54533,"derivative":{"exercise_price":1.41,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":54533},"source":{"system":"sec-edgar","filing":"0001104659-23-129254","document":"tm2333705-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923129254/tm2333705-6_4seq1.xml","form_type":"4"}},{"id":1700180,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":40969,"kind":"person","name":"Boctor Fady","position":1,"cik":"0001833394","reported_name":"Boctor Fady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-26T22:07:49.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":49645,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49645,"source":{"system":"sec-edgar","filing":"0001104659-23-129254","document":"tm2333705-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923129254/tm2333705-6_4seq1.xml","form_type":"4"}},{"id":1700179,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-26T22:07:14.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on April 10, 2024, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. through the vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-23-129252","document":"tm2333705-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923129252/tm2333705-2_4seq1.xml","form_type":"4"}},{"id":1700178,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":82913,"kind":"person","name":"Arnold Mitchell","position":1,"cik":"0001841497","reported_name":"Arnold Mitchell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-26T22:06:56.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vested 100% upon grant."}],"balance_after":20000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-23-129251","document":"tm2333705-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923129251/tm2333705-5_4seq1.xml","form_type":"4"}},{"id":1700177,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-26T22:06:09.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on April 10, 2024, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. through the vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-23-129250","document":"tm2333705-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923129250/tm2333705-1_4seq1.xml","form_type":"4"}},{"id":1700176,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-26T22:05:30.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on April 10, 2024, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. through the vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-23-129247","document":"tm2333705-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923129247/tm2333705-4_4seq1.xml","form_type":"4"}},{"id":1911398,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-04-28T22:03:08.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":false,"shares":6050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,050 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,050 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6050},"source":{"system":"sec-edgar","filing":"0001104659-23-053227","document":"tm2313909-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923053227/tm2313909-4_4seq1.xml","form_type":"4"}},{"id":1911397,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-28T22:03:08.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":true,"shares":6050,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,050 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":8314,"source":{"system":"sec-edgar","filing":"0001104659-23-053227","document":"tm2313909-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923053227/tm2313909-4_4seq1.xml","form_type":"4"}},{"id":1911396,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-04-28T22:02:12.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":false,"shares":6050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,050 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,050 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6050},"source":{"system":"sec-edgar","filing":"0001104659-23-053226","document":"tm2313909-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923053226/tm2313909-3_4seq1.xml","form_type":"4"}},{"id":1911395,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-28T22:02:12.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":true,"shares":6050,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,050 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":8346,"source":{"system":"sec-edgar","filing":"0001104659-23-053226","document":"tm2313909-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923053226/tm2313909-3_4seq1.xml","form_type":"4"}},{"id":1911394,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-04-28T22:01:28.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":false,"shares":6050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,050 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,050 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6050},"source":{"system":"sec-edgar","filing":"0001104659-23-053225","document":"tm2313909-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923053225/tm2313909-2_4seq1.xml","form_type":"4"}},{"id":1911393,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-28T22:01:28.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":true,"shares":6050,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,050 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":8314,"source":{"system":"sec-edgar","filing":"0001104659-23-053225","document":"tm2313909-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923053225/tm2313909-2_4seq1.xml","form_type":"4"}},{"id":1911392,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-04-28T22:00:34.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":false,"shares":6722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,722 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,722 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6722},"source":{"system":"sec-edgar","filing":"0001104659-23-053224","document":"tm2313909-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923053224/tm2313909-1_4seq1.xml","form_type":"4"}},{"id":1911391,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-28T22:00:34.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":true,"shares":6722,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,722 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":11237,"source":{"system":"sec-edgar","filing":"0001104659-23-053224","document":"tm2313909-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923053224/tm2313909-1_4seq1.xml","form_type":"4"}},{"id":1921051,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-12T22:01:36.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the one-year anniversary of the date of grant, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. (the \"Company\") through the vesting date."}],"balance_after":39000,"derivative":{"exercise_price":0.99,"expiration_date":"2033-04-10","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001104659-23-044713","document":"tm2312600-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923044713/tm2312600-4_4seq1.xml","form_type":"4"}},{"id":1921050,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-12T22:01:15.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the one-year anniversary of the date of grant, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. (the \"Company\") through the vesting date."}],"balance_after":39000,"derivative":{"exercise_price":0.99,"expiration_date":"2033-04-10","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001104659-23-044712","document":"tm2312600-3_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923044712/tm2312600-3_4seq.xml","form_type":"4"}},{"id":1921049,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-12T22:00:48.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the one-year anniversary of the date of grant, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. (the \"Company\") through the vesting date."}],"balance_after":39000,"derivative":{"exercise_price":0.99,"expiration_date":"2033-04-10","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001104659-23-044711","document":"tm2312600-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923044711/tm2312600-2_4seq1.xml","form_type":"4"}},{"id":1921048,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-12T22:00:29.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the one-year anniversary of the date of grant, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. (the \"Company\") through the vesting date."}],"balance_after":39000,"derivative":{"exercise_price":0.99,"expiration_date":"2033-04-10","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001104659-23-044709","document":"tm2312600-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923044709/tm2312600-1_4seq1.xml","form_type":"4"}},{"id":2046520,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-01-25T21:17:26.000Z","date":"2023-01-20","kind":"exercise","acquired":false,"shares":2264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,264 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,264 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2264},"source":{"system":"sec-edgar","filing":"0001104659-23-006547","document":"tm234334-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923006547/tm234334-4_4seq1.xml","form_type":"4"}},{"id":2046519,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T21:17:26.000Z","date":"2023-01-20","kind":"exercise","acquired":true,"shares":2264,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,264 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":2264,"source":{"system":"sec-edgar","filing":"0001104659-23-006547","document":"tm234334-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923006547/tm234334-4_4seq1.xml","form_type":"4"}},{"id":2046522,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-01-25T21:17:04.000Z","date":"2023-01-20","kind":"exercise","acquired":false,"shares":2515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,515 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,515 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2515},"source":{"system":"sec-edgar","filing":"0001104659-23-006546","document":"tm234334-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923006546/tm234334-3_4seq1.xml","form_type":"4"}},{"id":2046521,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T21:17:04.000Z","date":"2023-01-20","kind":"exercise","acquired":true,"shares":2515,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,515 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":4515,"source":{"system":"sec-edgar","filing":"0001104659-23-006546","document":"tm234334-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923006546/tm234334-3_4seq1.xml","form_type":"4"}},{"id":2046516,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-01-25T21:16:40.000Z","date":"2023-01-20","kind":"exercise","acquired":false,"shares":2264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,264 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,264 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2264},"source":{"system":"sec-edgar","filing":"0001104659-23-006545","document":"tm234334-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923006545/tm234334-2_4seq1.xml","form_type":"4"}},{"id":2046515,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T21:16:40.000Z","date":"2023-01-20","kind":"exercise","acquired":true,"shares":2264,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,264 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":2264,"source":{"system":"sec-edgar","filing":"0001104659-23-006545","document":"tm234334-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923006545/tm234334-2_4seq1.xml","form_type":"4"}},{"id":2046518,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-01-25T21:15:50.000Z","date":"2023-01-20","kind":"exercise","acquired":false,"shares":2264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,264 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,264 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2264},"source":{"system":"sec-edgar","filing":"0001104659-23-006542","document":"tm234334-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923006542/tm234334-1_4seq1.xml","form_type":"4"}},{"id":2046517,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T21:15:50.000Z","date":"2023-01-20","kind":"exercise","acquired":true,"shares":2264,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,264 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":2296,"source":{"system":"sec-edgar","filing":"0001104659-23-006542","document":"tm234334-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923006542/tm234334-1_4seq1.xml","form_type":"4"}},{"id":2299486,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-11T21:01:54.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":60505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date."}],"balance_after":60505,"derivative":{"underlying":"Common Stock","underlying_shares":60505},"source":{"system":"sec-edgar","filing":"0001104659-22-044717","document":"tm2212468d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922044717/tm2212468d4_4.xml","form_type":"4"}},{"id":2299485,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-11T21:01:19.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":67227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date."}],"balance_after":67227,"derivative":{"underlying":"Common Stock","underlying_shares":67227},"source":{"system":"sec-edgar","filing":"0001104659-22-044715","document":"tm2212468d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922044715/tm2212468d3_4.xml","form_type":"4"}},{"id":2299484,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-11T21:00:56.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":60505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date."}],"balance_after":60505,"derivative":{"underlying":"Common Stock","underlying_shares":60505},"source":{"system":"sec-edgar","filing":"0001104659-22-044713","document":"tm2212468d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922044713/tm2212468d2_4.xml","form_type":"4"}},{"id":2299483,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-11T21:00:32.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":60505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date."}],"balance_after":60505,"derivative":{"underlying":"Common Stock","underlying_shares":60505},"source":{"system":"sec-edgar","filing":"0001104659-22-044711","document":"tm2212468d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922044711/tm2212468d1_4.xml","form_type":"4"}},{"id":2440239,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-07T21:45:45.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":22642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date"}],"balance_after":22642,"derivative":{"underlying":"Common Stock","underlying_shares":22642},"source":{"system":"sec-edgar","filing":"0001104659-22-002307","document":"tm222320d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922002307/tm222320d4_4.xml","form_type":"4"}},{"id":2440238,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-07T21:45:04.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":25156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date"}],"balance_after":25156,"derivative":{"underlying":"Common Stock","underlying_shares":25156},"source":{"system":"sec-edgar","filing":"0001104659-22-002306","document":"tm222320d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922002306/tm222320d3_4.xml","form_type":"4"}},{"id":2440237,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-07T21:44:27.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":22642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date"}],"balance_after":22642,"derivative":{"underlying":"Common Stock","underlying_shares":22642},"source":{"system":"sec-edgar","filing":"0001104659-22-002304","document":"tm222320d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922002304/tm222320d2_4.xml","form_type":"4"}},{"id":2440236,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-07T21:43:42.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":22642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date"}],"balance_after":22642,"derivative":{"underlying":"Common Stock","underlying_shares":22642},"source":{"system":"sec-edgar","filing":"0001104659-22-002303","document":"tm222320d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922002303/tm222320d1_4.xml","form_type":"4"}},{"id":2454530,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":2,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":3,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":4,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":5,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2022-01-03T06:13:52.000Z","date":"2021-12-22","kind":"purchase","acquired":true,"shares":109329,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"See Note (1) in Exhibit 99.1."}],"balance_after":109329,"derivative":{"exercise_price":3.5,"exercise_date":"2021-12-27","expiration_date":"2026-12-28","underlying":"Common Stock","underlying_shares":109329},"source":{"system":"sec-edgar","filing":"0001104659-22-000036","document":"tm2136682-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000110465922000036/tm2136682-1_4seq1.xml","form_type":"4"}},{"id":2454529,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":2,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":3,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":4,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":5,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-01-03T06:13:52.000Z","date":"2021-12-22","kind":"purchase","acquired":true,"shares":145773,"price":3.43,"value":500001.39,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"See Note (1) in Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"See Note (1) in Exhibit 99.1."}],"balance_after":5703544,"source":{"system":"sec-edgar","filing":"0001104659-22-000036","document":"tm2136682-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000110465922000036/tm2136682-1_4seq1.xml","form_type":"4"}},{"id":2492266,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":2,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":3,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":4,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":5,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2021-11-30T14:49:21.000Z","date":"2021-11-29","kind":"purchase","acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"See Note (1) in Exhibit 99.1."}],"balance_after":375000,"derivative":{"exercise_price":3.5,"exercise_date":"2021-12-02","expiration_date":"2026-12-02","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001104659-21-144901","document":"tm2134252-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000110465921144901/tm2134252-1_4.xml","form_type":"4"}},{"id":2492265,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":2,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":3,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":4,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":5,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-11-30T14:49:21.000Z","date":"2021-11-29","kind":"purchase","acquired":true,"shares":500000,"price":3,"value":1500000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"See Note (1) in Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"See Note (1) in Exhibit 99.1."}],"balance_after":5557771,"source":{"system":"sec-edgar","filing":"0001104659-21-144901","document":"tm2134252-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000110465921144901/tm2134252-1_4.xml","form_type":"4"}},{"id":2537432,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":2,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":3,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":4,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":5,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2021-10-21T08:47:14.000Z","date":"2021-10-18","kind":"purchase","acquired":true,"shares":1661807,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"See Note (1) in Exhibit 99.1."}],"balance_after":1661807,"derivative":{"exercise_price":1.715,"exercise_date":"2021-10-18","expiration_date":"2026-10-18","underlying":"Common Stock","underlying_shares":1661807},"source":{"system":"sec-edgar","filing":"0001567619-21-018515","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000156761921018515/doc1.xml","form_type":"4"}},{"id":2537431,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":2,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":3,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":4,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":5,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-10-21T08:47:14.000Z","date":"2021-10-18","kind":"purchase","acquired":true,"shares":1661807,"price":1.715,"value":2849999.005,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"See Note (1) in Exhibit 99.1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 185,414 shares of Common Stock previously held of record by Metuchen Therapeutics, LLC (\"MT\") that were received by JCP III SM AIV, L.P. as a liquidating distribution. In prior reports, the reporting persons beneficially owned the 185,414 previously held by MT."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"See Note (1) in Exhibit 99.1."}],"balance_after":5057771,"source":{"system":"sec-edgar","filing":"0001567619-21-018515","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000156761921018515/doc1.xml","form_type":"4"}},{"id":2613156,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":82913,"kind":"person","name":"Arnold Mitchell","position":1,"cik":"0001841497","reported_name":"Arnold Mitchell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Prin. Acct. Off/Prin. Fin. Off"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-05T22:02:37.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the options vested 30% on the date of grant, 30% shall vest upon the first annual anniversary of the date of grant and 40% shall vest upon the second annual anniversary of the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":3.21,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-014526","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761921014526/doc1.xml","form_type":"4"}},{"id":2613155,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":136591,"kind":"person","name":"Gesek Andrew","position":1,"cik":"0001833990","reported_name":"Gesek Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Timm Medical"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-05T22:01:45.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the options vested 30% on the date of grant, 30% shall vest upon the first annual anniversary of the date of grant and 40% shall vest upon the second annual anniversary of the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":3.21,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001567619-21-014525","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761921014525/doc1.xml","form_type":"4"}},{"id":2752197,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-09T20:17:11.000Z","date":"2021-04-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the options vested 25% on the date of grant, 25% shall vest upon the six-month anniversary of the date of grant and the remainder shall vest in equal installments over the following four fiscal quarters."}],"balance_after":50000,"derivative":{"exercise_price":3.18,"expiration_date":"2031-04-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-007865","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761921007865/doc1.xml","form_type":"4"}},{"id":2752196,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-04-09T20:16:50.000Z","date":"2021-04-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the options vested 25% on the date of grant, 25% shall vest upon the six-month anniversary of the date of grant and the remainder shall vest in equal installments over the following four fiscal quarters."}],"balance_after":50000,"derivative":{"exercise_price":3.18,"expiration_date":"2031-04-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-007864","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761921007864/doc1.xml","form_type":"4"}},{"id":2752195,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-09T20:16:18.000Z","date":"2021-04-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the options vested 25% on the date of grant, 25% shall vest upon the six-month anniversary of the date of grant and the remainder shall vest in equal installments over the following four fiscal quarters."}],"balance_after":50000,"derivative":{"exercise_price":3.18,"expiration_date":"2031-04-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-007863","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761921007863/doc1.xml","form_type":"4"}},{"id":2752194,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":1235,"kind":"person","name":"Bernstein Bruce","position":1,"cik":"0001665472","reported_name":"Bernstein Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-09T20:15:54.000Z","date":"2021-04-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the options vested 25% on the date of grant, 25% shall vest upon the six-month anniversary of the date of grant and the remainder shall vest in equal installments over the following four fiscal quarters."}],"balance_after":50000,"derivative":{"exercise_price":3.18,"expiration_date":"2031-04-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-007862","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761921007862/doc1.xml","form_type":"4"}},{"id":2752193,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-09T20:15:24.000Z","date":"2021-04-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the options vested 25% on the date of grant, 25% shall vest upon the six-month anniversary of the date of grant and the remainder shall vest in equal installments over the following four fiscal quarters."}],"balance_after":50000,"derivative":{"exercise_price":3.18,"expiration_date":"2031-04-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-007861","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761921007861/doc1.xml","form_type":"4"}},{"id":2826903,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":40969,"kind":"person","name":"Boctor Fady","position":1,"cik":"0001833394","reported_name":"Boctor Fady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. & Chief Comm. Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-03-02T00:16:09.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":215669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vested 50% as of February 19, 2021, the date of grant, and the remainder vest in equal installments on the first and second annual anniversaries thereof."}],"balance_after":215669,"derivative":{"exercise_price":3.74,"expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":215669},"source":{"system":"sec-edgar","filing":"0001567619-21-005214","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761921005214/doc1.xml","form_type":"4"}},{"id":2931593,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131837,"kind":"organization","name":"Juggernaut Partners III GP, L.P.","position":2,"cik":"0001835421","reported_name":"Juggernaut Partners III GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131838,"kind":"organization","name":"Juggernaut Partners III GP, Ltd.","position":3,"cik":"0001835433","reported_name":"Juggernaut Partners III GP, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131836,"kind":"organization","name":"METP Holdings LLC","position":4,"cik":"0001836319","reported_name":"METP Holdings LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131835,"kind":"organization","name":"JCP III SM AIV, L.P.","position":5,"cik":"0001835386","reported_name":"JCP III SM AIV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134385,"kind":"organization","name":"Metuchen Therapeutics, LLC","position":6,"cik":"0001836798","reported_name":"Metuchen Therapeutics, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-12-28T19:46:47.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":3395964,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amended Form 4 is being filed to add Reporting Persons and to adjust the number of securities acquired to account for the same."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"See Note (1) in Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"See Note (2) in Exhibit 99.1."}],"balance_after":3395964,"source":{"system":"sec-edgar","filing":"0001567619-20-021618","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835421/000156761920021618/doc1.xml","form_type":"4/A","original_submission_date":"2020-12-03"}},{"id":2958847,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":136591,"kind":"person","name":"Gesek Andrew","position":1,"cik":"0001833990","reported_name":"Gesek Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Timm Medical"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-12-04T02:59:17.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":97,"ownership":{"direct":false,"nature":"By Metuchen Therapeutics, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 196.43 units of Metuchen Pharmaceuticals, LLC (\"Metuchen\") in connection with the merger (the \"Merger\") of Metuchen into Petros Pharmaceuticals, Inc. (\"Petros\").  Mr. Gesek's holding of units of Metuchen was on a look-through basis based on proportionate ownership of Metuchen Therapeutics, LLC, which owned 550,000 units of Metuchen. On the effective date of the Merger, the closing price of Petros was $3.99 per share."}],"balance_after":97,"source":{"system":"sec-edgar","filing":"0001567619-20-020632","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761920020632/doc1.xml","form_type":"4"}},{"id":2958846,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":144921,"kind":"person","name":"Lavan Keith","position":1,"cik":"0001833345","reported_name":"Lavan Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-12-04T02:58:34.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":975,"ownership":{"direct":false,"nature":"By Metuchen Therapeutics, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 1964.29 units of Metuchen Pharmaceuticals, LLC (\"Metuchen\") in connection with the merger (the \"Merger\") of Metuchen into Petros Pharmaceuticals, Inc. (\"Petros\").  Mr. Lavan's holding of units of Metuchen was on a look-through basis based on proportionate ownership of Metuchen Therapeutics, LLC, which owned 550,000 units of Metuchen. On the effective date of the Merger, the closing price of Petros was $3.99 per share."}],"balance_after":975,"source":{"system":"sec-edgar","filing":"0001567619-20-020631","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761920020631/doc1.xml","form_type":"4"}},{"id":2958845,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":31192,"kind":"person","name":"SHULMAN JOHN D","position":1,"cik":"0001208886","reported_name":"SHULMAN JOHN D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-12-04T02:57:25.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":3382416,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"See Note (1) in Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"See Note (2) in Exhibit 99.1."}],"balance_after":3382416,"source":{"system":"sec-edgar","filing":"0001567619-20-020630","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761920020630/doc1.xml","form_type":"4"}},{"id":2961087,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Received in connection with the Transactions in exchange for a stock option to acquire 100,000 shares of Neurotrope common stock for $0.972 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F18","text":"All shares subject to the option vested in connection with the Transactions."}],"balance_after":20000,"derivative":{"exercise_price":4.86,"expiration_date":"2030-11-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961086,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Received in connection with the Transactions in exchange for a stock option to acquire 10,000 shares of Neurotrope common stock for $0.82 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"All shares subject to the option shall vest on March 20, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":2000,"derivative":{"exercise_price":4.1,"expiration_date":"2030-03-20","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961085,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Received in connection with the Transactions in exchange for a stock option to acquire 10,000 shares of Neurotrope common stock for $4.06 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"All shares subject to the option are vested as of the date hereof."}],"balance_after":2000,"derivative":{"exercise_price":20.3,"expiration_date":"2029-03-15","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961084,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Received in connection with the Transactions in exchange for a stock option to acquire 150,000 shares of Neurotrope common stock for $3.93 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"28,125 shares subject to the option are vested as of the date hereof and the remaining shares subject to the option shall vest quarterly through January 22, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":30000,"derivative":{"exercise_price":19.65,"expiration_date":"2029-01-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961083,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Received in connection with the Transactions in exchange for a stock option to acquire 10,000 shares of Neurotrope common stock for $8.912 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"All shares subject to the option are vested as of the date hereof."}],"balance_after":2000,"derivative":{"exercise_price":44.56,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961082,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":33400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Received in connection with the Transactions in exchange for a stock option to acquire 167,000 shares of Neurotrope common stock for $19.62 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"All shares subject to the option are vested as of the date hereof."}],"balance_after":33400,"derivative":{"exercise_price":98.1,"expiration_date":"2027-04-11","underlying":"Common Stock","underlying_shares":33400},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961081,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in connection with the Transactions in exchange for a stock option to acquire 10,000 shares of Neurotrope common stock for $19.10 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"All shares subject to the option are vested as of the date hereof."}],"balance_after":2000,"derivative":{"exercise_price":95.5,"expiration_date":"2027-03-17","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961080,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":24855,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in connection with the Transactions in exchange for a stock option to acquire 124,275 shares of Neurotrope common stock for $10.56 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All shares subject to the option are vested as of the date hereof."}],"balance_after":24855,"derivative":{"exercise_price":52.8,"expiration_date":"2026-11-22","underlying":"Common Stock","underlying_shares":24855},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961079,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":1875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in connection with the Transactions in exchange for a stock option to acquire 9,375 shares of Neurotrope common stock for $19.20 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1,623 shares subject to the option are vested as of the date hereof and the remaining shares subject to the option shall vest daily through August 4, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":1875,"derivative":{"exercise_price":96,"expiration_date":"2026-08-04","underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}},{"id":2961078,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-12-03T02:10:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 100,000 shares of Neurotrope, Inc. (\"Neurotrope\") common stock in connection with the transactions (the \"Transactions\") contemplated by that certain Agreement and Plan of Merger, dated as of May 17, 2020 (the \"the Original Merger Agreement\"), as amended by the First Amendment to the Original Merger Agreement (the \"First Amendment\") , dated as of July 23, 2020 and the Second Amendment to the Original Merger Agreement, dated as of September 30, 2020 (the \"Second Amendment\" and, together with the Original Merger Agreement and the First Amendment, the \"Merger Agreement\") by and among Petros Pharmaceuticals, Inc. (the \"Company\"), Neurotrope, PM Merger Sub 1, LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company (\"Merger Sub 1\"), PN Merger Sub 2, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (\"Merger Sub 2\"), and Metuchen Pharmaceuticals LLC, a Delaware limited liability company."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001104659-20-131729","document":"tm2037431-3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465920131729/tm2037431-3_4.xml","form_type":"4"}}]}